References
1. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology. 2019;115(4):432-450.
2. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.Cochrane Database Syst Rev. 2012(3):Cd000510.
3. Zhang L, Cao HY, Zhao S, Yuan LJ, Han D, Jiang H, Wu S, Wu HM. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials. Pulm Pharmacol Ther. 2015;34:46-54.
4. Sardesai S, Biniwale M, Wertheimer F, Garingo A, Ramanathan R. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future. Pediatr Res. 2017;81(1-2):240-248.
5. Fischer HS, Buhrer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics.2013;132(5):e1351-1360.
6. Carrasco Loza R, Villamizar Rodriguez G, Medel Fernandez N. Ventilator-Induced Lung Injury (VILI) in Acute Respiratory Distress Syndrome (ARDS): Volutrauma and Molecular Effects. Open Respir Med J. 2015;9:112-119.
7. Leone F, Trevisanuto D, Cavallin F, Parotto M, Zanardo V. Efficacy of INSURE during nasal CPAP in preterm infants with respiratory distress syndrome. Minerva Pediatr. 2013;65(2):187-192.
8. Najafian B, Fakhraie SH, Afjeh SA, Kazemian M, Shohrati M, Saburi A. Early surfactant therapy with nasal continuous positive airway pressure or continued mechanical ventilation in very low birth weight neonates with respiratory distress syndrome. Iran Red Crescent Med J.2014;16(4):e12206.
9. Gomes Cordeiro AM, Fernandes JC, Troster EJ. Possible risk factors associated with moderate or severe airway injuries in children who underwent endotracheal intubation. Pediatr Crit Care Med.2004;5(4):364-368.
10. Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration-a survey. Eur J Pediatr.2017;176(2):147-154.
11. Wyckoff M, Aziz K, Escobedo M, et al. Part 13: Neonatal Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2015;132:S543-560.
12. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.PLoS med. 2009;6(7):e1000100.
13. Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0.. The Cochrane Collaboration. 2011. p 33–49. Available from: www.handbook.cochrane.org.
14. Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, Siegel J, Avenarius S, von der Wense A, Vochem M, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.Lancet. 2011;378(9803):1627-1634.
15. Heidarzadeh M, Mirnia K, Hoseini MB, Sadeghnia A, Akrami F, Balila M, Ghojazadeh M, Shafai F. Surfactant Administration via Thin Catheter during Spontaneous Breathing: Randomized Controlled Trial in Alzahra hospital. Iran J Neonatol . 2013;4(2):5-9.
16. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics. 2013;131(2):e502-509.
17. Mirnia K, Heidarzadeh M, Hosseini MB. Comparison Outcome of Surfactant Administration Via Tracheal Catheterization During Spontaneous Breathing with Insure. Med J Islamic World Acad Sci.2013;21(4):143-148.
18. Bao Y, Zhang G, Wu M, Ma L, Zhu J. A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center. BMC Pediatr. 2015;15:21.
19. Kribs A, Roll C, Göpel W, Wieg C, Groneck P, Laux R, Teig N, Hoehn T, Böhm W, Welzing L, et al. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr. 2015;169(8):723-730.
20. Mohammadizadeh M, Ardestani AG, Sadeghnia AR. Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome. J Res Pharm Pract. 2015;4(1):31-36.
21. Mosayebi Z, Kadivar M, Taheri-Derakhsh N, Nariman S, Mahdi Marashi S, Farsi Z. A Randomized Trial Comparing Surfactant Administration Using InSurE Technique and the Minimally Invasive Surfactant Therapy in Preterm Infants (28 to 34 Weeks of Gestation) with Respiratory Distress Syndrome. J Compr Ped. 2017;In Press(In Press): :e60724.
22. Halim A, Shirazi H, Riaz S, Gul S, Ali W. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.J Coll Physicians Surg Pak. 2019;29(3):226-330.
23. Jena SR, Bains HS, Pandita A, et al. Surfactant therapy in premature babies: SurE or InSurE. Pediatr Pulmonol. 2019;54(11):1747-1752.
24. Gupta BK, Saha AK, Mukherjee S, Saha B. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial. Eur J Pediatr.2020;179(8):1287-1293.
25. Han T, Liu H, Zhang H, Guo M, Zhang X, Duan Y, Sun F, Liu X, Zhang X, Zhang M, et al. Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China. Front Pediatr. 2020;8:182.
26. Yang G, Hei M, Xue Z, Zhao Y, Zhang X, Wang C. Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks. Medicine (Baltimore). 2020;99(9):e19216.
27. Lin HJ, Du LZ, Ma XL, Shi LP, Pan JH, Tong XM, Li QP, Zhou JG, Yi B, Liu L, et al. Mortality and Morbidity of Extremely Low Birth Weight Infants in the Mainland of China: A Multi-center Study. Chin Med J (Engl). 2015;128(20):2743-2750.
28. Wu F, Liu G, Feng Z, Tan X, Yang C, Ye X, Dai Y, Liang W, Ye X, Mo J, et al. Short-term outcomes of extremely preterm infants at discharge: a multicenter study from Guangdong province during 2008-2017. BMC Pediatr. 2019;19(1):405.
29. Clyman RI. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia. Semin Perinatol. 2013;37(2):102-107.
30. Sato K, Nakashima T. Histopathologic changes in laryngeal mucosa of extremely low-birth weight infants after endotracheal intubation.Ann Otol Rhinol Laryngol. 2006;115(11):816-823.
31. Sharma GK, Ahuja GS, Wiedmann M, Osann KE, Su E, Heidari AE, Jing JC, Qu Y, Lazarow F, Wang A, et al. Long-Range Optical Coherence Tomography of the Neonatal Upper Airway for Early Diagnosis of Intubation-related Subglottic Injury. Am J Respir Crit Care Med.2015;192(12):1504-1513.
32. Abdel-Latif M, Osborn D. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome. Database Syst Rev. 2012;10:CD008310.
33. Barbosa RF, Simoes ESAC, Silva YP. A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates.J Pediatr (Rio J). 2017;93(4):343-350.
34. Roberts KD, Brown R, Lampland AL, et al. Laryngeal Mask Airway for Surfactant Administration in Neonates: A Randomized, Controlled Trial.J Pediatr. 2018;193:40-46 e41.
35. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group. Br Med J (Clin Res Ed). 1987;294(6578):991-996.
36. Barkhuff W, Soll R. Novel Surfactant Administration Techniques: Will They Change Outcome? Neonatology. 2019;115(4):411-422.
37. Kurepa D, Perveen S, Lipener Y, Kakkilaya V. The use of less invasive surfactant administration (LISA) in the United States with review of the literature. J Perinatol. 2019;39(3):426-432.
38. Björklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, Vilstrup CT. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res. 1997;42(3):348-355.
39. Herting E, Hartel C, Gopel W. Less invasive surfactant administration (LISA): chances and limitations. Arch Dis Child Fetal Neonatal Ed. 2019;104(6):F655-F659.
40. More K, Sakhuja P, Shah PS. Minimally invasive surfactant administration in preterm infants: a meta-narrative review. JAMA Pediatr. 2014;168(10):901-908.
41. Isayama T, Iwami H, McDonald S, Beyene J. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.JAMA. 2016;316(6):611-624.
42. Langhammer K, Roth B, Kribs A, Göpel W, Kuntz L, Miedaner F. Treatment and outcome data of very low birth weight infants treated with less invasive surfactant administration in comparison to intubation and mechanical ventilation in the clinical setting of a cross-sectional observational multicenter study. Eur J Pediatr.2018;177(8):1207-1217.
43. Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed.2017;102(1):F17-F23.